Jacqueline Trouillas

Author

Also Known As

J Trouillas, J. TROUILLAS, J. Trouillas, Jacqueline Trouillas, The members of HYPOPRONOS, Trouillas Jacqueline, Trouillas, J.

163

Publications

8.9K

Citations

H-Index

Concepts

All Affiliations

Inserm Université Claude Bernard Lyon 1 Hospices Civils de Lyon Centre National de la Recherche Scientifique Centre de Recherche en Neurosciences de Lyon

About

Jacqueline Trouillas is an author at Inserm specializing in medicine, pathology, and endocrinology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	31	1.9K
2	Cell Biology	9	9	525
3	Health Sciences	2	2	71
4	Cellular Physiology	2	2	139
5	Natural Sciences	1	1	39

Jacqueline Trouillas

Publications

6.4K

Citations

H-Index

Page 1

	Year	Citations
A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal Guido Rindi, David S. Klimstra, Behnoush Abedi‐Ardekani, Modern Pathology	2018	1.1K
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal Olivera Casar‐Borota, Philippe Chanson, Etienne Delgrange, Endocrine Related Cancer Neuro-oncologyAnterior PituitaryPituitary GlandPituitary Neuroendocrine TumorMedicine	2017	345
Sex-Related Difference in the Growth of Prolactinomas: A Clinical and Proliferation Marker Study<sup>1</sup> Etienne Delgrange, Jacqueline Trouillas, Dominique Maiter, The Journal of Clinical Endocrinology & Metabolism	1997	275
Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016 Ann McCormack, Olaf M. Dekkers, Stephan Petersenn, European Journal of Endocrinology	2018	269
Pituitary Tumors and Hyperplasia in Multiple Endocrine Neoplasia Type 1 Syndrome (MEN1): A Case-Control Study in a Series of 77 Patients Versus 2509 Non-MEN1 Patients Jacqueline Trouillas, F Labat-Moleur, Nathalie Stürm, The American Journal of Surgical Pathology Large Pituitary TumorsPituitary TumorsPituitary GlandNon-men1 PatientsMedicine	2008	229
Temozolomide Treatment in Aggressive Pituitary Tumors and Pituitary Carcinomas: A French Multicenter Experience Gérald Raverot, Nathalie Stürm, Florence de Fraipont, The Journal of Clinical Endocrinology & Metabolism	2010	222
Prognostic Factors in Prolactin Pituitary Tumors: Clinical, Histological, and Molecular Data from a Series of 94 Patients with a Long Postoperative Follow-Up Gérald Raverot, Anne Wierinckx, Emmanuelle Dantony, The Journal of Clinical Endocrinology & Metabolism	2010	187
Heterogeneous Genetic Background of the Association of Pheochromocytoma/Paraganglioma and Pituitary Adenoma: Results From a Large Patient Cohort Judit Dénes, Francesca Swords, Eleanor Rattenberry, The Journal of Clinical Endocrinology & Metabolism	2014	180
Risk of Recurrence in Pituitary Neuroendocrine Tumors: A Prospective Study Using a Five-Tiered Classification Gérald Raverot, Emmanuelle Dantony, J. Beauvy, The Journal of Clinical Endocrinology & Metabolism	2017	167
A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors Anne Wierinckx, Carole Auger, Pauline Devauchelle, Endocrine Related Cancer	2007	165

Page 1